Evidence map›Paper›PMID 33540115›Full record

ArticleClinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases2021

Corrigendum to "Review of trials currently testing treatment and prevention of COVID-19" [Clin Microbiol Infect 26.8 (2020) 988-998].

Paraskevi C Fragkou, Drifa Belhadi, Nathan Peiffer-Smadja, Charalampos D Moschopoulos, François-Xavier Lescure, Hannah Janocha, Emmanouil Karofylakis, Yazdan Yazdanpanah, France Mentré, Chrysanthi Skevaki and 3 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Paraskevi C Fragkou4th Department of Internal Medicine, Medical School, National and Kapodistrian University of Athens, Attikon University Hospital, Athens, Greece; European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Respiratory Viruses (ESGREV), Switzerland. Electronic address: evita.fragou@gmail.com.
Drifa BelhadiUniversité de Paris, IAME, INSERM, F-75018, Paris, France; Département d'Epidémiologie Biostatistiques et Recherche Clinique, Hôpital Bichat - Claude-Bernard, AP-HP, 75018, Paris, France. Electronic address: drifa.belhadi@aphp.fr.
Nathan Peiffer-SmadjaUniversité de Paris, IAME, INSERM, F-75018, Paris, France; Infectious Diseases Department, Bichat-Claude Bernard Hospital, Assistance-Publique Hôpitaux de Paris, Paris, France. Electronic address: nathan.peiffer-smadja@inserm.fr.
Charalampos D Moschopoulos4th Department of Internal Medicine, Medical School, National and Kapodistrian University of Athens, Attikon University Hospital, Athens, Greece. Electronic address: bmosxop@yahoo.gr.
François-Xavier LescureUniversité de Paris, IAME, INSERM, F-75018, Paris, France; Infectious Diseases Department, Bichat-Claude Bernard Hospital, Assistance-Publique Hôpitaux de Paris, Paris, France. Electronic address: xavier.lescure@aphp.fr.
Hannah JanochaInstitute of Laboratory Medicine, Universities of Giessen and Marburg Lung Centre (UGMLC), Philipps University Marburg, German Centre for Lung Research (DZL), Marburg, Germany. Electronic address: hannah.Janocha@med.uni-giessen.de.
Emmanouil Karofylakis4th Department of Internal Medicine, Medical School, National and Kapodistrian University of Athens, Attikon University Hospital, Athens, Greece. Electronic address: manoskarofilakis@gmail.com.
Yazdan YazdanpanahUniversité de Paris, IAME, INSERM, F-75018, Paris, France; Infectious Diseases Department, Bichat-Claude Bernard Hospital, Assistance-Publique Hôpitaux de Paris, Paris, France. Electronic address: yazdan.yazdanpanah@aphp.fr.
France MentréUniversité de Paris, IAME, INSERM, F-75018, Paris, France; Département d'Epidémiologie Biostatistiques et Recherche Clinique, Hôpital Bichat - Claude-Bernard, AP-HP, 75018, Paris, France. Electronic address: france.mentre@inserm.fr.
Chrysanthi SkevakiEuropean Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Respiratory Viruses (ESGREV), Switzerland; Institute of Laboratory Medicine, Universities of Giessen and Marburg Lung Centre (UGMLC), Philipps University Marburg, German Centre for Lung Research (DZL), Marburg, Germany. Electronic address: Chrysanthi.Skevaki@uk-gm.de.
Cédric LaouénanUniversité de Paris, IAME, INSERM, F-75018, Paris, France; Département d'Epidémiologie Biostatistiques et Recherche Clinique, Hôpital Bichat - Claude-Bernard, AP-HP, 75018, Paris, France. Electronic address: cedric.laouenan@inserm.fr.
Sotirios Tsiodras4th Department of Internal Medicine, Medical School, National and Kapodistrian University of Athens, Attikon University Hospital, Athens, Greece; European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Respiratory Viruses (ESGREV), Switzerland. Electronic address: sotirios.tsiodras@gmail.com.
ESCMID Study Group for Respiratory Viruses

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID33540115
PMCPMC8445272

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.